Nkarta (NKTX) Stock: Buy, Sell, or Hold?
NKTX - Nkarta, Inc. Common Stock
$2.58
0.02 (0.59%)
▲
5d:
-6.36%
30d:
-6.87%
90d:
-21.97%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When NKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NKTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NKTX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NKTX is currently trading at $2.58, which is considered oversold relative to its 30-day fair value range of $2.65 to $2.93.
Technical Outlook: Technically, NKTX is showing sideways momentum. The price is currently testing key support at $2.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NKTX scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.83 (+320.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NKTX is showing sideways momentum. The price is currently testing key support at $2.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NKTX scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.83 (+320.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.65 -
$2.93
Company Quality Score
42/100
(HOLD)
Options IV Signal
39th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 39th percentile)
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 320.7% below Wall St target ($10.83)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.65 -
$2.93
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.38
(14.6%)
Support & Resistance Levels
Support Level
$2.52
Resistance Level
$2.99
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.47
Wall Street Target
$10.83
(+320.7%)
Share & Embed Analysis
Last updated: October 03, 2026 12:24 AM ET
Data refreshes hourly during market hours. Next update: 1:24 AM
Data refreshes hourly during market hours. Next update: 1:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
